3//SEC Filing
Q Therapeutics, Inc. 3
Accession 0001209191-15-081813
CIK 0001366541operating
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 5:14 PM ET
Size
5.5 KB
Accession
0001209191-15-081813
Insider Transaction Report
Form 3
Q Therapeutics, Inc.[NONE]
Green David A
Chief Financial Officer
Holdings
Options to Purchase Common Stock
Exercise: $0.70From: 2016-06-30Exp: 2025-11-16→ Common Stock (100,000 underlying)Options to Purchase Common Stock
Exercise: $0.70From: 2016-11-10Exp: 2025-11-17→ Common Stock (400,000 underlying)
Footnotes (2)
- [F1]28% of the shares vest on November 10, 2016, date and 2% per month thereafter.
- [F2]Options would vest immediately upon closing an equity and/or debt financing in the cumulative amount of $15 million on or prior to June 30, 2016.
Documents
Issuer
Q Therapeutics, Inc.
CIK 0001366541
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001366541
Filing Metadata
- Form type
- 3
- Filed
- Nov 22, 7:00 PM ET
- Accepted
- Nov 23, 5:14 PM ET
- Size
- 5.5 KB